← Back to Clinical Trials
Recruiting NCT06539988

NCT06539988 Advancing Decisions About Virtual Service Encounters

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06539988
Status Recruiting
Phase
Sponsor VA Office of Research and Development
Condition Health Care Costs
Study Type INTERVENTIONAL
Enrollment 600 participants
Start Date 2026-04-01
Primary Completion 2027-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Clinician Coaching SessionsPersonalized text messages to patients

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 600 participants in total. It began in 2026-04-01 with a primary completion date of 2027-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Expanded availability of virtual care encounters in Primary Care provides new opportunities to improve Veterans' outcomes by aligning encounter modalities with their needs and preferences. Yet, Veterans and their Primary Care physicians (PCPs) lack personalized information about the benefits and costs of different Primary Care modalities that is needed to maximize the value of Primary Care encounters. To address this problem, in this study the investigators will use surveys and interviews to identify what Veterans and PCPs perceive to be the benefits and optimal uses of different Primary Care encounter modalities. They will then supplement their existing system for communicating encounter costs to Veterans and PCPs with new interactive messaging about benefits and optimal uses of different encounter modalities. Finally, this novel Advancing Decisions about Virtual Service Encounters (ADViSE) intervention will be optimized through user-centered refinement before evaluating its effects on Veteran-centered outcomes, use of virtual care, and intermediate health outcomes in a randomized controlled trial (RCT).

Eligibility Criteria

Inclusion Criteria: * Veteran inclusion criteria are having an upcoming face-to-face (F2F), telephone, or VA Video Connect (VVC) appointment in the next 8 to 12 weeks * Having at least 3 Primary Care F2F, telephone, or VVC encounters in the previous 12 months * Able to provide informed consent * Willing and able to receive text messages from the VA Patient Engagement, Tracking, and Long-term Support (PETALS) platform Exclusion Criteria: * Veteran exclusion criteria are a CDW diagnosis of mild cognitive impairment, dementia, or a psychotic disorder

Contact & Investigator

Central Contact

Jeffrey T Kullgren, MD MPH MS

✉ Jeffrey.Kullgren@va.gov

📞 (734) 845-5290

Principal Investigator

Jeffrey T. Kullgren, MD MPH MS

PRINCIPAL INVESTIGATOR

VA Ann Arbor Healthcare System, Ann Arbor, MI

Frequently Asked Questions

Who can join the NCT06539988 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Health Care Costs. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06539988 currently recruiting?

Yes, NCT06539988 is actively recruiting participants. Contact the research team at Jeffrey.Kullgren@va.gov for enrollment information.

Where is the NCT06539988 trial being conducted?

This trial is being conducted at Ann Arbor, United States.

Who is sponsoring the NCT06539988 clinical trial?

NCT06539988 is sponsored by VA Office of Research and Development. The principal investigator is Jeffrey T. Kullgren, MD MPH MS at VA Ann Arbor Healthcare System, Ann Arbor, MI. The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology